Journal of Cancer Survivorship: The value of immunotherapy for survivors of stage IV non-small cell lung cancer

In this groundbreaking study of cancer patients treated with immunotherapy for stage IV cancer, ReD has illuminated the particular state of patients who survive longer than their initial prognosis. These patients are able to achieve a state of normalcy, despite having a terminal condition.